This profile is for informational purposes only and is not medical advice. Consult a healthcare professional before use. See full terms.
Phenibut
Phenibut is a synthetic GABA derivative developed in Russia that crosses the blood-brain barrier. It activates GABA-B receptors to produce anxiolytic, sedative, and mood-enhancing effects. While effective for anxiety, it carries substantial risks of dependence and withdrawal with regular use.
Benefits
What is Phenibut?
Phenibut (beta-phenyl-gamma-aminobutyric acid) is a synthetic derivative of the inhibitory neurotransmitter GABA, developed in the Soviet Union in the 1960s. It differs from regular GABA by the addition of a phenyl ring, which allows it to cross the blood-brain barrier - something that GABA itself cannot do efficiently when taken orally. In Russia, it is approved as a pharmaceutical (brand name Noofen or Anvifen) for anxiety, insomnia, and various neurological conditions. It was famously included in the medical kit of Soviet cosmonauts.
Phenibut's primary action is on GABA-B receptors, the same target as the pharmaceutical baclofen. This produces dose-dependent effects ranging from mild relaxation and social ease at low doses to significant sedation and euphoria at higher doses. Many users report that phenibut provides remarkable anxiety relief while maintaining (or even enhancing) cognitive function and sociability - a combination rare among anxiolytics.
However, phenibut's efficacy is matched by serious risks. Tolerance develops rapidly with regular use (often within days), and physical dependence can occur with as few as 1-2 weeks of daily use. Withdrawal from phenibut can be severe and medically dangerous, resembling benzodiazepine or alcohol withdrawal with symptoms including rebound anxiety, insomnia, tremors, and in severe cases, psychosis and seizures.
- GABA-B agonism: Phenibut's primary mechanism is agonism of GABA-B receptors, producing inhibition of neuronal excitability. This reduces anxiety, promotes relaxation, and at higher doses produces sedation and muscle relaxation.
- Voltage-dependent calcium channel blockade: Phenibut blocks alpha-2-delta subunit-containing voltage-dependent calcium channels (the same target as gabapentin and pregabalin), reducing excitatory neurotransmitter release.
- Weak GABA-A activity: At higher doses, phenibut may also activate GABA-A receptors, contributing to its sedative and anxiolytic effects.
- Dopamine modulation: Some evidence suggests phenibut may influence dopamine levels, which could explain the mood-enhancing and motivational effects reported by users.
- Cortisol reduction: By reducing anxiety and stress response, phenibut may lower cortisol levels, though this is likely a secondary effect rather than a direct mechanism.
- Low dose: 250-500 mg (mild relaxation, subtle anxiety reduction)
- Moderate dose: 500-1000 mg (noticeable anxiolysis, mood enhancement)
- High dose: 1000-2000 mg (strong anxiolysis, sedation - higher risk)
- Onset: 2-4 hours (slow onset is a common cause of accidental overdosing by impatient users)
- Duration: 4-8 hours for primary effects, with residual effects lasting longer
CRITICAL: Do NOT use more than 1-2 times per week maximum. NEVER use daily. Tolerance builds extremely rapidly and dependence can develop within days of consecutive use. The slow onset means effects may not be felt for 2-4 hours - do NOT re-dose thinking it hasn't worked.
- DEPENDENCE AND WITHDRAWAL: Phenibut produces rapid tolerance and physical dependence. Withdrawal can be severe and potentially life-threatening, with symptoms including severe anxiety, insomnia, tremors, hallucinations, psychosis, and seizures. Medical supervision may be required for withdrawal.
- Never combine with: Alcohol, benzodiazepines, opioids, GHB, or other CNS depressants. Combinations can cause respiratory depression and death.
- Legal status: Prescription drug in Russia, Latvia, and some other countries. Unregulated in many Western countries but banned in Australia. Check local laws.
- Overdose risk: The slow onset (2-4 hours) leads many inexperienced users to take additional doses before the first has taken effect, resulting in accidental overdose.
- Pregnancy: Avoid completely. No safety data and GABA-ergic drugs can affect foetal neurodevelopment.
- Driving: May impair motor coordination and reaction time, especially at higher doses. Do not drive or operate machinery.
Natural Sources & Forms
- Bulk powder: Available from nootropic vendors (typically phenibut HCl or phenibut FAA/free amino acid form)
- Capsules: Pre-measured doses available from some supplement companies
- Pharmaceutical: Sold as Noofen, Anvifen, or Bifren in Russia and some Eastern European countries
- Forms: Phenibut HCl (more common, acidic) and Phenibut FAA (free amino acid form, less acidic, suitable for sublingual use)
Frequently Asked Questions
Phenibut is a synthetic GABA derivative developed in Russia that crosses the blood-brain barrier. It activates GABA-B receptors to produce anxiolytic, sedative, and mood-enhancing effects. While effective for anxiety, it carries substantial risks of dependence and withdrawal with regular use.
The key benefits of Phenibut include: Anxiety & Calm, Focus, Mood, Motivation, Sleep, Stress Relief.
GABA-B agonism: Phenibut's primary mechanism is agonism of GABA-B receptors, producing inhibition of neuronal excitability. This reduces anxiety, promotes relaxation, and at higher doses produces sedation and muscle relaxation. Voltage-dependent calcium channel blockade: Phenibut blocks alpha-2-delta subunit-containing voltage-dependent calcium channels (the same target as gabapentin and pregabalin), reducing excitatory neurotransmitter release. Weak GABA-A activity: At higher doses, phenibut may also activate GABA-A receptors, contributing to its sedative and anxiolytic effects. Dopamine modulation: Some evidence suggests phenibut may influence dopamine levels, which could explain the mood-enhancing and motivational effects reported by users. Cortisol reduction: By reducing anxiety and stress response, phenibut may lower cortisol levels, though this is likely a secondary effect rather than a direct mechanism.
Low dose: 250-500 mg (mild relaxation, subtle anxiety reduction) Moderate dose: 500-1000 mg (noticeable anxiolysis, mood enhancement) High dose: 1000-2000 mg (strong anxiolysis, sedation - higher risk) Onset: 2-4 hours (slow onset is a common cause of accidental overdosing by impatient users) Duration: 4-8 hours for primary effects, with residual effects lasting longer CRITICAL: Do NOT use more than 1-2 times per week maximum. NEVER use daily. Tolerance builds extremely rapidly and dependence can develop within days of consecutive use. The slow onset means effects may not be felt for 2-4 hours - do NOT re-dose thinking it hasn't worked.
DEPENDENCE AND WITHDRAWAL: Phenibut produces rapid tolerance and physical dependence. Withdrawal can be severe and potentially life-threatening, with symptoms including severe anxiety, insomnia, tremors, hallucinations, psychosis, and seizures. Medical supervision may be required for withdrawal. Never combine with: Alcohol, benzodiazepines, opioids, GHB, or other CNS depressants. Combinations can cause respiratory depression and death. Legal status: Prescription drug in Russia, Latvia, and some other countries. Unregulated in many Western countries but banned in Australia. Check local laws. Overdose risk: The slow onset (2-4 hours) leads many inexperienced users to take additional doses before the first has taken effect, resulting in accidental overdose. Pregnancy: Avoid completely. No safety data and GABA-ergic drugs can affect foetal neurodevelopment. Driving: May impair motor coordination and reaction time, especially at higher doses. Do not drive or operate machinery.
Overall Rating
Log in to rate this nootropic.
Comments
Log in to leave a comment.
No comments yet. Be the first to share your experience!